The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bendamustine rituximab (BR) versus ibrutinib (Ibr) as primary therapy for Waldenström macroglobulinemia (WM): An international collaborative study.
 
Jithma P. Abeykoon
No Relationships to Disclose
 
Shaji Kumar
Honoraria - BeiGene
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Cellectar; Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)
 
Jorge J. Castillo
Consulting or Advisory Role - Abbvie/Pharmacyclics; Beigene; Janssen; Polyneuron Pharmaceuticals; Roche/Genentech
Research Funding - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Janssen (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
 
Shirley D'Sa
No Relationships to Disclose
 
Efstathios Kastritis
Honoraria - Amgen; Genesis Pharma; Janssen Oncology; Pfizer; Prothena; Takeda
Consulting or Advisory Role - Amgen; Genesis Pharma; Janssen Oncology; Pfizer; Prothena; Takeda
Research Funding - Amgen (Inst); Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Genesis Pharma; Janssen Oncology; Pfizer; Takeda
 
Eric Durot
No Relationships to Disclose
 
Encarl Uppal
No Relationships to Disclose
 
Pierre Morel
Honoraria - Janssen
Consulting or Advisory Role - BeiGene
 
Jonas Paludo
Research Funding - Biofourmis (Inst); Karyopharm Therapeutics (Inst)
 
Reema Tawfiq
No Relationships to Disclose
 
Shayna Sarosiek
Research Funding - Acrotech Biopharma (Inst)
 
M Olabisi Ogunbiyi
No Relationships to Disclose
 
Pascale Cornillet-Lefebvre
No Relationships to Disclose
 
Robert A. Kyle
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Pfizer; Pharmacyclics
 
Alain Delmer
No Relationships to Disclose
 
Morie A. Gertz
Honoraria - Abbvie; Akcea Therapeutics; Amgen; Apellis Pharmaceuticals; Celgene; Janssen Oncology; Juno/Celgene; Med Learning Group; Prothena; Research to Practice; Sanofi; Telix Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb/Sanofi; Prothena
Travel, Accommodations, Expenses - Celgene; Novartis; Prothena
 
Meletios A. Dimopoulos
Honoraria - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Janssen-Cilag; Takeda
 
Steven P. Treon
Honoraria - Abbvie/Pharmacyclics; BeiGene; Janssen Oncology
Consulting or Advisory Role - Beigene; Bristol Myers Squibb; Janssen; Pharmacyclics; X4 Pharma
Research Funding - Abbvie (Inst); Beigene (Inst); Bristol Myers Squibb (Inst); Lilly (Inst); Pharmacyclics; X4 Pharma (Inst)
Patents, Royalties, Other Intellectual Property - my institution holds patents related to use of MYD88 and CXCR4 testing for which a predetermined financial distribution to the laboratory and individuals is provided. I have not received any income to this date related to these patents. (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
Other Relationship - Beigene; Janssen; Pharmacyclics
 
Stephen M. Ansell
Honoraria - Research to Practice; WebMD
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); AI Therapeutics (Inst); Bristol-Myers Squibb (Inst); Regeneron (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
 
Prashant Kapoor
Honoraria - BeiGene; Cellectar; Clinical Care Options; GlaxoSmithKline (Inst); Karyopharm Therapeutics; Pharmacyclics; Sanofi (Inst)
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Regeneron (Inst); Sanofi (Inst); Sorrento Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Sanofi